GlassScriptPhysician profile
Nathan W Conroy
NPI 1598742066
$480.50
in general payments reported to CMS, 2019-2025
13 companies · $48.13 in 2025
The $48.13 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $216 · 2022: $91.10 · 2023: $87.89 · 2024: $37.68 · 2025: $48.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $95.73 | 2021-2023 | Mounjaro |
| Abbott Laboratories | $92.31 | 2021-2023 | Freestyle Libre 3 |
| Novo Nordisk INC | $48.83 | 2022-2025 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $45.69 | 2021 | |
| Merck Sharp & Dohme LLC | $40.71 | 2022-2024 | Vaxelis, Gardasil 9, Capvaxive |
| Pfizer INC. | $32.47 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $28.14 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $20.27 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.66 | 2021 | |
| Glaxosmithkline, LLC. | $15.95 | 2025 | Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $15.13 | 2023 | |
| Exact Sciences Corporation | $14.24 | 2025 | The Cologuard Plus Collection Kit |
| Eisai INC. | $12.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Conroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.